Abstract
The antiherpes drug acyclovir was found to inhibit HIV following its phosphorylation by human herpesviruses, providing a hypothesis to explain the observed beneficial effects of acyclovir therapy on HIV viral load and HIV disease progression. This report underscores the importance of studying HIV in the context of microbial copathogens.
Original language | English (US) |
---|---|
Pages (from-to) | 194-195 |
Number of pages | 2 |
Journal | Cell Host and Microbe |
Volume | 4 |
Issue number | 3 |
DOIs | |
State | Published - Sep 11 2008 |